Elsevier Health has developed a standardized, objective test to help instructors assess nursing students' clinical judgment and practice readiness.
The Latest
Anjali Rao, MD, has been named chief medical officer of Redwood City, Calif.-based Dignity Health Sequoia Hospital.
JohnRoss Rizzo, MD, NYU Langone's director of disability inclusion, is personally familiar with the challenges of navigating hospitals using conventional wayfinding signage and approaches. As a legally blind physician-scientist, navigating and orienting himself in a complex academic medical center has,…
Isaiah Nathaniel, CPHIMS, Senior Vice President and Chief Information Officer at Delaware Valley Community Health, Inc., discusses the integration of AI into healthcare strategies to enhance patient care. He shares his goals for improving efficiency in the new year through…
In this episode of the Becker’s Healthcare podcast, Jakob Emerson sits down with John Brownlee, CEO and Co-Founder of Vidscrips, to explore the evolution of patient education through digital innovation. They discuss the impact of video in ASCs, how Vidscrips…
In this episode of the Becker’s Healthcare podcast, Jakob Emerson sits down with John Brownlee, CEO and Co-Founder of Vidscrips, to explore the evolution of patient education through digital innovation. They discuss the impact of video in ASCs, how Vidscrips…
In this episode, Editor-in-Chief Laura Dyrda joins Scott Becker to discuss key healthcare trends, including the latest executive order on price transparency, potential Medicaid cuts, and rising patient volumes in hospitals across the U.S.
In this episode, Editor-in-Chief Alan Condon joins Scott Becker to discuss the latest hospital financial trends, Prime Healthcare’s acquisition of eight Ascension hospitals, and UnitedHealthcare’s plan to reduce prior authorization requirements.
The American Society of Health-System Pharmacists has partnered with ShiftRx, a staffing and workforce management platform, to help address critical shortages in the pharmacy workforce.
The FDA has reprimanded Dexcel and its affiliate Edenbridge Pharmaceuticals for "false or misleading" promotional claims regarding its brand-name drug Hemady.